Serum NT-proBNP concentrations in pediatric patients with a history of idiopathic cardiac arrhythmias: a pilot study. | IF: 5.6 |
Galectin-3 as a marker of arrhythmia in children and adolescents: are we on the right track? | MEiN: |
Przegląd biochemicznych markerów dysfunkcji mięśnia sercowego. | MEiN: 70.000 |
Electrocardiographic repolarization parameters in children with arrhythmias and excessive body weight. | IF: 3.6 |
Anticancer activity of melatonin and metformin alone and in combination against melanoma and breast cancer cells. | IF=0.4 |
Usefulness of galectin-3 as a biochemical marker to detect ventricular and supraventricular arrhythmias in children. | IF: 2.8 |
Associations between selected ADRB1 and CYP2D6 gene polymorphisms in children with ventricular and supraventricular arrhythmias. | IF: 2.4 |
Pterostilbene-mediated inhibition of cell proliferation and cell death induction in amelanotic and melanotic melanoma | IF: 5.6 |
In vitro and in silico study on the effect of carvedilol and sorafenib alone and in combination on the growth and inflammatory response of melanoma cells. | IF: 4.1 |
The unusual history of stroke due to coagulopathy caused by SARS-CoV-2 infection in a 14-year-old boy with two heart tumors. | IF: 3.3 |
| Mechanism of pterostilbene-induced cell death in HT-29 colon cancer cells. Joanna Wawszczyk, Katarzyna Jesse, Sławomir Smolik, Małgorzata Kapral. Molecules 2022; Vol.27, No.2, p.1-19, id. art. 369 | IF: 4.927 |
| The influence of TNF-α on the expression profile of key enzymes of steroidogenesis in H295R cells. Beniamin Grabarek, Krzysztof Cholewa, Jolanta Lodowska Post.Dermatol.Alergol./Adv.Dermatol.Allergol. 2021; Vol.38, No.3, p.404-411. | IF: 1.664 |
| Expression levels of serum circulating microRNAs in pediatric patients with ventricular and supraventricular arrhythmias. Ewa Moric-Janiszewska, Sławomir Smolik, Aleksandra Morka, Lesław Szydłowski, Małgorzata Kapral. Adv.Med.Sci. 2021; Vol.66, No.2, p.411-417. | IF: 2.852 |
| Krążące miRNA jako potencjalne biomarkery w ocenie ryzyka wystąpienia arytmii serca, jej nawrotu, lub skuteczności leczenia antyarytmicznego. Circulating miRNAs as potential biomarkers in assessing the risk of cardiac arrhythmia, its recurrence, or the effectiveness of antiarrhythmic therapy. Ewa Moric-Janiszewska, Karolina Zapletal Diagn.Lab. 2021 : T.57, nr 2, s.119-129. | MEiN: 40.000 |
| Możliwości personalizacji farmakoterapii cukrzycy typu 2 na podstawie profilu genetycznego pacjenta. Klaudia Borgiasz, Aleksandra Szewerniak, Karolina Palmąka, Antoni Łazarczyk, Sławomir Smolik, Ludmiła Węglarz Farm.Pol. 2019; T.75, nr 6, s.300-305. | MEiN: 70.000 |
| Regulation of microRNA-155 and its related genes expression by inositol hexaphosphate in colon cancer cells. Małgorzata Kapral, Joanna Wawszczyk, Ludmiła Węglarz Molecules 2019; Vol.24, No.22, p.1-16, 4153. | IF: 3.267 |
| Sporządzanie ex tempore płynnych doustnych postaci leków w aptekach szpitali pediatrycznych. Preparation of extemporaneous oral liquid medications in childrens hospital pharmacies. Arkadiusz Gruchlik, Sławomir Smolik Farm.Pol. 2018; T.74, nr 4, s.260-264. | MEiN: 8.000 |
| The induction of cytotoxicity by pterostilbene in various human cancer cell lines. Joanna Wawszczyk, Katarzyna Jesse, Aleksandra Szewerniak, Małgorzata Kapral, Ludmiła Węglarz Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.5, p.1161-1166. | IF: 0.447 |
| Inositol hexaphosphate inhibits proliferation and induces apoptosis of colon cancer cells by suppressing the AKT/mTOR signaling pathway. Małgorzata Kapral, Joanna Wawszczyk, Katarzyna Jesse, Monika Paul-Samojedny, Dariusz Kuśmierz, Ludmiła Węglarz. Molecules 2017; Vol.22, No.10, p.1-17, 1657 | IF: 3.098 |
| Modulating effect of inositol hexaphosphate on arachidonic acid-dependent pathways in colon cancer cells. Małgorzata Kapral, Joanna Wawszczyk, Stanisław Sośnicki, Katarzyna Jesse, Ludmiła Węglarz. Prostaglandins Other Lipid Mediat. 2017; Vol.131, p.41-48 | IF: 2.991 |
| Molecular targets of metformin antitumor action. Stanisław Sośnicki, Małgorzata Kapral, Ludmiła Węglarz. Pharmacol.Rep. 2016; Vol.68, No.5, p.918-925 | IF: 2.587 |
| Antiproliferative effect of inositol hexaphosphate on human skin melanoma cells in vitro. Joanna Wawszczyk, Małgorzata Kapral, Jolanta Lodowska, Katarzyna Jesse, Andrzej Hollek, Ludmiła Węglarz. Acta Pol.Pharm.-Drug Res. 2015; Vol.72, No.5, p.895-900 | IF: 0.877 |
| The effect of sulfasalazine and 5-aminosalicylic acid on the secretion of interleukin 8 by human colon myofibroblasts. Jolanta Lodowska, Arkadiusz Gruchlik, Daniel Wolny, Joanna Wawszczyk, Zofia Dzierżewicz, Ludmiła Węglarz. Acta Pol.Pharm.-Drug Res. 2015; Vol.72, No.5, p.917-921 | IF: 0.877 |
| Down-regulation of inducible nitric oxide synthase expression by inositol hexaphosphate in human colon cancer cells. Małgorzata Kapral, Joanna Wawszczyk, Stanisław Sośnicki, Ludmiła Węglarz. Acta Pol.Pharm.-Drug Res. 2015; Vol.72, No.4, p.705-711 | IF: 0.877 |
| Influence of inositol hexaphosphate on the expression of selected proliferation markers in IL-1β-stimulated intestinal epithelial cells. Małgorzata Kapral, Stanisław Sośnicki, Joanna Wawszczyk, Ludmiła Węglarz. Acta Pol.Pharm.-Drug Res. 2014; Vol.71, No.6, p.987-993 | IF: 0.737 |
| In vitro evaluation of antiproliferative and cytotoxic properties of pterostilbene against human colon cancer cells. Joanna Wawszczyk, Małgorzata Kapral, Andrzej Hollek, Ludmiła Węglarz. Acta Pol.Pharm.-Drug Res. 2014; Vol.71, No.6, p.1051-1055 | IF: 0.737 |
| CYP2C9 polymorphism in the pharmacological treatment of long QT patients. Sławomir Smolik, Ewa Moric-Janiszewska, Ludmiła Węglarz. Acta Pol.Pharm.-Drug Res. 2014; Vol.71, No.6, p.1103-1106 | IF: 0.737 |
